Detection of anti-cytokeratin 8 antibody in the serum of patients with cryptogenic fibrosing alveolitis and pulmonary fibrosis associated with collagen vascular disorders

Thorax

Volumn 53, Issue 11, 1998, Pages 969-974

  Dobashi, Naomi ^a   Fujita, Jiro ^a   Ohtsuki, Yuji ^e   Yamadori, Ichiro ^d   Yoshinouchi, Takeo ^b   Kamei, Tadashi ^c   Tokuda, Michiaki ^a   Hojo, Satoko ^a   Okada, Hiroki ^a   Takahara, Jiro ^a  

^a KAGAWA UNIVERSITY   (Japan)

^b Department of Respiratory Medicine   (Japan)

^c KAGAWA PREFECTURAL CENTRAL HOSPITAL   (Japan)

^d OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

^e KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

A549 cell; Antibody; Collagen vascular disorders; Cytokeratin 8; Idiopathic pulmonary fibrosis

Indexed keywords

AUTOANTIBODY; CYTOKERATIN; MESSENGER RNA; MONOCLONAL ANTIBODY;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ARTICLE; CLINICAL ARTICLE; COLLAGEN DISEASE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROSING ALVEOLITIS; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG EMPHYSEMA; LUNG FIBROSIS; MALE; PNEUMONIA; PRIORITY JOURNAL; SARCOIDOSIS; TUMOR CELL LINE; VASCULAR DISEASE;

EID: 7844226612     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.53.11.969     Document Type: Article

References (39)

1. Crystal RG, Bitterman PB, Rennard SI, et al. Interstitial lung diseases of unknown cause. Disorders characterized by chronic inflammation of the lower respiratory tract. N Engl J Med 1984;310:154-66.
2. Peterson MW, Monick M, Hunninghake GW. Prognostic role of eosinophils in pulmonary fibrosis. Chest 1987;92: 51-6.
3. Cherniack RM. Bronchoalveolar lavage constituents in healthy individuals, interstitial pulmonary fibrosis and selected comparison groups. Am Rev Respir Dis 1990; 141(Suppl):S169-93.
4. Reynolds HY, Fulmer JD, Kazamierowski JA, et al. Analysis of cellular and protein content of bronchoalveolar lavage fluid from patients with idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis. J Clin Invest 1977;59: 165-75.
5. Wallace WAH, Roberts SN, Caldwell H, et al. Circulating antibodies to lung protein(s) in patients with cryptogenic fibrosing alveolitis. Thorax 1994;49:218-24.
6. Wallace WAH, Schofiels JA, Lamb D, et al. Localization of a pulmonary autoantigen in cryptogenic fibrosing alveolitis. Thorax 1994;49:1139-45.
7. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680.
8. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets. Proc Nat Acad Sci USA 1979;76:4350-4.
9. Kradin RL, Divertie MB, Colvin RB, et al. Usual interstitial pneumonitis is a T cell alveolitis. Clin Immunol Immunopathol 1986;40:224-35.
10. Haslam PL, Thomson B, Mohammed I, et al. Circulating immune complexes in patients with cyptogenic fibrosing alveolitis. Clin Exp Immunol 1979;37:381-90.
11. Dreisen RB, Schwarz MI, Theofilopoulos AN, et al. Circulating immune complexes in the idiopathic interstitial pneumonias. N Engl J Med 1978;298:353-7.
12. Turner- Warwick M, Doniach D. Auto-antibodies in idiopathic pulmonary fibrosis. BMJ 1965;1:886-91.
13. Wallaert B. Subclinical alveolitis in immunologic systemic disorders. Lung 1990;168(Suppl):974-83.
14. Haslam PL. Evaluation of alveolitis by studies of lung biopsies. Lung 1990;168(Suppl):984-92.
15. Emura M, Nagi S, Takeuchi M, et al. In vitro production of B cell growth factors and B cell differentiation factors by peripheral blood mononuclear cells and bronchoalveolar lavage T lymphocytes from patients with idiopathic pulmonary fibrosis. Clin Exp Immunol 1990;82:133-9.
16. Ehringer R. Similar frequency of auto-antibodies against type II pneumocytes and Clara cells in patients with interstitial lung disease and healthy persons. Klin Wochenshr 1991;69:297-302.
17. Corrin B, Dewar A, Rodriguez-Roisin R, et al. Fine structural changes in cryptogenic fibrosing alveolitis and asbestosis. J Pathol 1985;147:107-19.
18. Schwartz MI, Dreisen RB, Pratt DS, et al. Immunofluorescent pattern in idiopathic interstitial pneumonia. J Lab Clin Med 1978;91:929-35.
19. Meliconi R, Bestagno M, Sturani C, et al. Autoantibodies to DNA topoisomerase II in cryptogenic fibrosing alveolitis and connective tissue diseases. Clin Exp Immunol 1989;76:184-9.
20. Ohta K, Watanabe J, Hirai K, et al. High prevalence serum antibodies to hepatitis C virus in idiopathic pulmonary fibrosis. Am Rev Respir Dis 1992;145:A218.
21. Kurki P, Virtanen I. The detection of human antibodies against cytoskeletal components. J Immunol Methods 1984; 67:209-23.
22. Alarcon-Segovia D, Ruiz-Arguelles A, Fishbein E. Antibody to nuclear ribonucleoprotein penetrates live human mononuclear cells through Fc receptors. Nature 1978;271:67-9.
23. Alarcon-Segovia D, Ruiz-Arguelles A, Fishbein E. Antibody penetration into living cells. I. Intranuclear immunoglobulin in peripheral blood mononuclear cells in mixed connective tissue disease and systemic lupus crythemotosus. Clin Exp Immunol 1979;35:364-75.
24. Alarcon-Segovia D, Ruiz-Arguelles A, Fishbein E. Antibody penetration into living cells. II. antiribonucleoprotein IgG penetrates into Tc lymphocytes causing their deletion and the abrogation of suppressor function. J Immunol 1979;122: 1855-62.
25. Alarcon-Segovia D. Penetration of antinuclear antibodies into immunoregulatory T cells: pathogenetic role in the connective tissue diseases. Clin Immmunol Allergy 1981;1: 117-26.
26. Sturgess JM, Chao J, Turner JAP. Transposition of ciliary microtubules: another cause of impaired ciliary motility. N Engl J Med 1980;303:318-22.
27. Runger-Brandle E, Gabbiani G. The role of cytoskeletal and cytocontractile element in pathologic processes. Am J Pathol 1983;110:361-92.
28. Kurki P, Miettinen A, Salaspuro M, et al. Cytoskeleton antibodies in chronic active hepatitis, primary biliary cirrhosis, and alcoholic liver disease. Hepatology 1983;3:297-302.
29. Kurki P, Helve T, Virtanen I. Antibodies to cytoplasmic intermediate filaments in rheumatic diseases. J Rheumatol 1983;10:558-62.
30. Kurki P, Virtanen I. The detection of human antibodies against cytoskeletal components. J Immunol Methods 1984; 67:209-23.
31. Zauli D, Crespi C, Dall'amore P, et al. Antibodies to the cytoskeleton components and other autoantibodies in inflammatory bowel disease. Digestion 1985;32:140-4.
32. Grubauer G, Romani N Kofler H, et al. Apototic keratin bodies as autoantigen causing the production of IgM-anti-keratin intermediate filament autoantibodies. J Invest Dermatol 1986;87:466-71.
33. Hintner H, Romani N, Stanzl U, et al. Phagocytosis of keratin filament aggregates following opsonization with IgG-anti-keratin filament autoantibodies. J Invest Dermatol 1987;88:176-82.
34. Tron F, Le Guern C, Cazenave PA, Bach JF. Intrastain recurrent idiotypes among anti-DNA antibodies of (NZB × NZW) F1 hybrid mice. Eur J Immunol 1982;12:761-6.
35. Tron F, Jacob L, Bach JF. Murine monoclonal anti-DNA antibodies with an absolute specificity for DNA have a large amount of idiotype diversity. Proc Nat Acad Sci USA 1983;80:6024-7.
36. Iyonaga K, Miyafuji M, Suga M, et al. Alterations in cytokeratin expression by the alveolar lining epithelial cells in lung tissue from patients with idiopathic pulmonary fibrosis. J Pathol 1997;182:217-24.
37. Kuwano K, Kunitake R, Kawasaki M, et al. p21Waf1/Cip1/ Sdi1 and p53 expression in association with DNA strand breaks in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1996;154:477-83.
38. Hojo S, Fujita J, Yamadori I, et al. Overexpression of p53 protein in interstitial lung diseases. Respir Med 1998;92: 184-90.
39. Mukhopadhyay T, Roth JA. p53 involvement in activation of the cytokeratin 8 gene in tumor cell lines. Anticancer Res 1996;16:105-12.